Gamma-aminobutyric acid (GABA) in the CSF of schizophrenic patients before and after neuroleptic treatment

D. Lichtshtein; J. Dobkin; R. P. Ebstein; J. Biederman; R. Rimon; R. H. Belmaker

doi:10.1192/bjp.132.2.145

Gamma-aminobutyric acid (GABA) in the CSF of schizophrenic patients before and after neuroleptic treatment

D. Lichtshtein, J. Dobkin, R. P. Ebstein, J. Biederman, R. Rimon, R. H. Belmaker

Research output: Contribution to journal › Article › peer-review

55 Scopus citations

Abstract

Gamma aminobutyric acid (GABA) levels in the CSF were measured in 9 normal individuals, 17 drug-free schizophrenic patients and 10 of these same schizophrenic patients after neuroleptic treatment. There was no significant difference between CSF level of GABA in the control group compared to those in schizophrenic patients; however, 6 of the 7 lowest GABA levels were from schizophrenic patients. There was a significant decline of 12 percent in mean GABA levels in the CSF after a mean of two months of neuroleptic treatment.

Original language	English
Pages (from-to)	145-148
Number of pages	4
Journal	British Journal of Psychiatry
Volume	132
Issue number	2
DOIs	https://doi.org/10.1192/bjp.132.2.145
State	Published - 1 Jan 1978

ASJC Scopus subject areas

Psychiatry and Mental health

Access to Document

10.1192/bjp.132.2.145

Cite this

@article{144db6b6fd6b4abeb28c70358afe669e,

title = "Gamma-aminobutyric acid (GABA) in the CSF of schizophrenic patients before and after neuroleptic treatment",

abstract = "Gamma aminobutyric acid (GABA) levels in the CSF were measured in 9 normal individuals, 17 drug-free schizophrenic patients and 10 of these same schizophrenic patients after neuroleptic treatment. There was no significant difference between CSF level of GABA in the control group compared to those in schizophrenic patients; however, 6 of the 7 lowest GABA levels were from schizophrenic patients. There was a significant decline of 12 percent in mean GABA levels in the CSF after a mean of two months of neuroleptic treatment.",

author = "D. Lichtshtein and J. Dobkin and Ebstein, {R. P.} and J. Biederman and R. Rimon and Belmaker, {R. H.}",

year = "1978",

month = jan,

day = "1",

doi = "10.1192/bjp.132.2.145",

language = "English",

volume = "132",

pages = "145--148",

journal = "British Journal of Psychiatry",

issn = "0007-1250",

publisher = "Cambridge University Press",

number = "2",

}

TY - JOUR

T1 - Gamma-aminobutyric acid (GABA) in the CSF of schizophrenic patients before and after neuroleptic treatment

AU - Lichtshtein, D.

AU - Dobkin, J.

AU - Ebstein, R. P.

AU - Biederman, J.

AU - Rimon, R.

AU - Belmaker, R. H.

PY - 1978/1/1

Y1 - 1978/1/1

N2 - Gamma aminobutyric acid (GABA) levels in the CSF were measured in 9 normal individuals, 17 drug-free schizophrenic patients and 10 of these same schizophrenic patients after neuroleptic treatment. There was no significant difference between CSF level of GABA in the control group compared to those in schizophrenic patients; however, 6 of the 7 lowest GABA levels were from schizophrenic patients. There was a significant decline of 12 percent in mean GABA levels in the CSF after a mean of two months of neuroleptic treatment.

AB - Gamma aminobutyric acid (GABA) levels in the CSF were measured in 9 normal individuals, 17 drug-free schizophrenic patients and 10 of these same schizophrenic patients after neuroleptic treatment. There was no significant difference between CSF level of GABA in the control group compared to those in schizophrenic patients; however, 6 of the 7 lowest GABA levels were from schizophrenic patients. There was a significant decline of 12 percent in mean GABA levels in the CSF after a mean of two months of neuroleptic treatment.

UR - http://www.scopus.com/inward/record.url?scp=0017799725&partnerID=8YFLogxK

U2 - 10.1192/bjp.132.2.145

DO - 10.1192/bjp.132.2.145

M3 - Article

C2 - 623945

AN - SCOPUS:0017799725

SN - 0007-1250

VL - 132

SP - 145

EP - 148

JO - British Journal of Psychiatry

JF - British Journal of Psychiatry

IS - 2

ER -

Gamma-aminobutyric acid (GABA) in the CSF of schizophrenic patients before and after neuroleptic treatment

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this